Navigation Links
Drug for Cancer to be on Pharmaceutical Benefits Scheme

The Federal Government and drug company, Roche are conducting talks to make the expensive anti-cancer treatment, Herceptin more widely available.//

According to Health Minister Tony Abbott discussions with manufacturer Roche has caused the delay in rushing Herceptin on to the Pharmaceutical Benefits Scheme (PBS).

Mr Abbott said,'It is important the Government try to get the best possible deal for taxpayers as well as the best possible deal for patients. So we are to some extent at least dependent on discussions with Roche, the company which makes the drug.'

Mortality rate caused by some types of breast cancer appears to be reduced with Herceptin. However the drug, which costs $50,000 to $60,000 per patient each year, is far too expensive for some victims.

The Government would have to spend about $100 million per year by listing Herceptin on the PBS but it would serve to make this drug more widely available.

According to Mr Abbot the listing of Herceptin was moving ahead more quickly than any other drug since he had become Health Minister.

He said, 'The Government has been pursuing this as quickly as possible. We expedited the consideration of Herceptin by the Therapeutic Goods Administration. We expedited the consideration by the Pharmaceutical Benefits Advisory Committee, and it will now get expedited consideration by Cabinet.'

The drug's benefits lie in reducing the chance of cancer reoccurring in women with a particular type of early-stage breast cancer.

If the Government accepts the recommendation of the Pharmaceutical Benefits Advisory Committee, the drug would be available to around 2100 patients for a subsidized price rather than the current cost.


'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: